98%
921
2 minutes
20
Background: Gestational diabetes and obstetrical cholestasis are common clinical conditions seen in clinical practice. There is evidence suggesting a coexisting relationship that could have a potential clinical implication related to stillbirth outcomes.
Objective: This study aimed to determine the prevalence of gestational diabetes in women with obstetrical cholestasis.
Study Design: A predefined protocol with a literature search was used to obtain all possible articles. A systematic review and meta-analysis of observational studies with quantifiable data published since 2010 were performed. Articles were evaluated and included in the study with specified criteria for the risk of bias using the Newcastle-Ottawa Scale. A meta-analysis was performed using Meta-analysis of Observational Studies in Epidemiology specifications to determine the prevalence of gestational diabetes in women with obstetrical cholestasis.
Results: A total of 16,748 patients with obstetrical cholestasis from 21 studies were included. The prevalence of gestational diabetes in women with obstetrical cholestasis was 13.9% (20 studies analyzed). Gestational diabetes was more common in women with obstetrical cholestasis than in women without obstetrical cholestasis (odds ratio, 2.129; 95% confidence interval, 1.697-2.670;10 studies). Gestational diabetes is twice more common in women with severe cholestasis than in women with mild cholestasis (odds ratio, 2.168; 95% confidence interval, 1.429-3.289; 4 studies).
Conclusion: There is an increase in the prevalence of gestational diabetes among women diagnosed with obstetrical cholestasis. Compared with women with mild cholestasis, the increased risk of gestational diabetes in women with severe cholestatis is more than doubled. This suggests that the 2 conditions may have some biological similarities that affect clinical outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563540 | PMC |
http://dx.doi.org/10.1016/j.xagr.2021.100013 | DOI Listing |
BJOG
September 2025
Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Objective: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM).
Design: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial.
Setting: Sweden, with risk-factor based screening for GDM.
J Am Pharm Assoc (2003)
September 2025
Department of Pharmacy, University of Rochester Medical Center, Rochester, NY.
Aims: Despite robust evidence supporting continuous glucose monitoring (CGM) use, successful utilization remains relatively low. This study aimed to determine percentage of patients with a baseline time in range (TIR) <70% who achieved TIR ≥ 70% when using CGM and identify patient variables associated with achievement and/or maintenance of TIR goal within our institution.
Materials And Methods: This was a retrospective, observational review of adult patients with diabetes using CGM for at least 6-months consecutively.
Horm Metab Res
September 2025
Department of Obstetrics, Fujian Maternity and Child Health Hospital, Fuzhou, China.
The non-insulin-based metabolic score for insulin resistance (METS-IR) is a recently developed index aimed at being a practical and efficient alternative biomarker of insulin resistance (IR). This study aimed to investigate the association between METS-IR in euthyroid women in the first trimester of pregnancy and pregnancy outcomes. A total of 1810 participants who gave birth at Fujian Maternity and Child Health Hospital from November 2018 to November 2019 were included in this study.
View Article and Find Full Text PDFDiabetes Metab Syndr
September 2025
School of Nursing, Capital Medical University, Beijing, China. Electronic address:
Introduction: Gestational diabetes mellitus (GDM) is a common pregnancy complication, with a significant risk of recurrence in subsequent pregnancies.
Aims: We aimed to explore the incidence and risk factors associated with the recurrence of GDM among women with a history of GDM.
Methods: We searched several databases (PubMed, Embase, Web of Science, Cochrane Library, Ovid, CINAHL, ProQuest, China Knowledge Resource Integrated Database, Wanfang Database, VIP Database, and China Biology Medicine Database) from January 1961 to June 2024.
J Med Internet Res
September 2025
Faculty of Medicine, The University of Sydney, Sydney, Australia.
Background: Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies and can have adverse short and long-term implications for women and their babies. eHealth interventions include any health service or treatment delivered using the internet and related technology that aims to facilitate, capture, or exchange knowledge. eHealth interventions are increasingly used across many health care settings with improved outcomes.
View Article and Find Full Text PDF